The main objectives of this study is to assess the safety and tolerability of ascending single and multiple oral doses of SAM-531 in healthy subjects
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Enrollment
56
Unnamed facility
Rueil-Malmaison, France
Pharmacokinetics, routine Lab tests, Vital signs, ECG
Time frame: 29 days
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.